<DOC>
	<DOCNO>NCT01402427</DOCNO>
	<brief_summary>Background Verapamil traditionally apply prophylactically transradial procedure prevent radial artery spasm . However , verapamil may side effect contraindicate clinical setting . Methods : During investigator‐initiated , randomize , double‐blind trial , evaluate need preventive verapamil administration . After vascular access establish , patient receive either 5 mg verapamil ( n=297 ) placebo ( n=294 ) . We compare rate access site conversion primary end point use superiority margin 5 % . Occurrence code break ( composite conversion unplanned use verapamil ) , overall verapamil use , procedural fluoroscopic time , contrast volume , subjective pain investigate secondary end point .</brief_summary>
	<brief_title>Is Verapamil In TransRadial Interventions OmittabLe ?</brief_title>
	<detailed_description />
	<mesh_term>Coronary Disease</mesh_term>
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Verapamil</mesh_term>
	<criteria>patient undergo transradial coronary angiography and/or percutaneous coronary intervention successful cannulation radial artery reduce leave ventricular systolic function ( LVEF &lt; 35 % ) significant aortic stenosis bradycardia ( &lt; 50/min . ) myocardial infarction complicate cardiogenic shock and/or high grade AV block</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2014</verification_date>
	<keyword>Coronary Artery Disease</keyword>
	<keyword>Coronary Angiography</keyword>
	<keyword>Percutaneous Coronary Intervention</keyword>
	<keyword>Transradial</keyword>
	<keyword>Radial Artery Spasm</keyword>
	<keyword>Verapamil</keyword>
	<keyword>Adverse Effects</keyword>
</DOC>